HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus

AIDS Research and Human Retroviruses

Volumn 18, Issue 8, 2002, Pages 567-576

  Long, E Michelle ^a   Rainwater, Stephanie M J ^a   Lavreys, Ludo ^a   Mandaliya, Kishorchandra ^a   Overbaugh, Julie ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; FEMALE; GENE IDENTIFICATION; GENOTYPE; HETEROSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX RATIO; VIROLOGY; VIRUS GENOME; VIRUS TRANSMISSION;

BASE SEQUENCE; DNA PRIMERS; FEMALE; GENETIC COMPLEMENTATION TEST; HIV-1; HUMANS; KENYA; MEMBRANE FUSION; PHYLOGENY; RADIOIMMUNOPRECIPITATION ASSAY; RECEPTORS, CCR5;

EID: 0036260635     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202753747914     Document Type: Article

References (43)

1. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
2. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission
3. HIV-1 primary infection in two pairs of patients: Difference in variants transmitted and clinical follow-up
4. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission
5. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals
6. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
7. Genetic restriction of HIV-1 infection and progression to AIDS by deletion allele of the CKR5 structural gene
8. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
9. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
10. Primary infections with HIV-1 of women and their offspring in Rwanda: Findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C
11. Gender differences in HIV-1 diversity at time of infection
12. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1
13. Hormonal contraception, sexually transmitted diseases, and the risk of heterosexual transmission of HIV-1
14. Preparation for AIDS vaccine evaluation in Mombasa, Kenya: Establishment of seronegative cohorts of commercial sex workers and trucking company employees
15. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms
16. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes
17. Nucleotide sequence of the AIDS virus, LAV
18. LAV revisited: Origins of the early HIV-1 isolates from Institut Pasteur
19. Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood
20. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays
21. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools
22. Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties
23. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene
24. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection
25. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro
26. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 Δ32
27. Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne
28. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies
29. Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation
30. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity
31. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
32. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
33. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
34. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
35. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
36. CD-4 dependent, antibody sensitive interactions between HIV-1 and its coreceptor CCR-5
37. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
38. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression
39. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection
40. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
41. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1